Evolus, Inc. (EOLS)
6.42
+0.10
(+1.58%)
USD |
NASDAQ |
May 07, 09:43
Evolus Free Cash Flow : -44.87M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Anika Therapeutics, Inc. | 1.039M |
| STAAR Surgical Co. | -40.05M |
| Quantum-Si, Inc. | -97.23M |
| Plus Therapeutics, Inc. | -20.84M |
| BioStem Technologies, Inc. | 6.589M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.952M |
| Cash from Investing (Quarterly) | -1.691M |
| Cash from Financing (Quarterly) | 7.619M |
| Free Cash Flow Per Share (Quarterly) | -0.1786 |
| Free Cash Flow to Equity (Quarterly) | -21.55M |
| Free Cash Flow to Firm (Quarterly) | -7.570M |
| Free Cash Flow Yield | -10.76% |